Regulatory Guidance for Pharmaceutical Nanotechnology

Nanotechnology represents a platform for developing revolutionary changes and improvements to many different aspects of pharmaceutical manufacturing. Also, the rate of nanotechnology discovery is proceeding more rapidly than practical applications can be found. Nanotechnology offers potential in pharmaceuticals for improving drug delivery systems, medical imaging, diagnosis, cancer therapy, and regenerative medicine. Although there is no international regulation or legislation specifically for nanomedicine, it is agreed worldwide that considerably more attention should be paid to the quality, safety, and efficacy of nanotechnology-based drugs. The US FDA and the European Medicines Agency have provided several regulatory guidelines for the development of nanomedicines.

  • Enable major investments and advances in basic sciences to translate faster into products to benefit consumer
  • Protect consumers by applying best possible science to support regulatory activities and decision-making
  • Keep pace with and fully utilize advances in innovation
  • Facilitating development of innovative products that benefit consumers and patients
  • Regulatory aspects towards approval of nanomedicine

Related Conference of Regulatory Guidance for Pharmaceutical Nanotechnology

October 23-24, 2025

21st Annual Meet on Pharmaceutical Sciences

Paris, France
November 11-12, 2025

6th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
December 30-31, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Regulatory Guidance for Pharmaceutical Nanotechnology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in